Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report / Diral, E.; Catalano, G.; Cicinelli, M. V.; Distefano, A.; Mastaglio, S.; Vago, L.; Lupo Stanghellini, M. T.; Bernardi, M.; Ponzoni, M.; Ciceri, F.; Carrabba, M. G.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 14:(2024). [10.3389/fonc.2024.1399894]
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report
Cicinelli M. V.;Distefano A.;Vago L.;Ponzoni M.;Ciceri F.Penultimo
;
2024-01-01
Abstract
Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.File | Dimensione | Formato | |
---|---|---|---|
fonc-14-1399894.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
401.12 kB
Formato
Adobe PDF
|
401.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.